Impax Laboratories, Inc. v. Aventis Pharmaceuticals, Inc.

468 F.3d 1366
Procedural entryThis page is a short order in Impax Laboratories, Inc. v. Aventis Pharmaceuticals, Inc.. Read the opinion of the Court — 545 F.3d 1312
Court of Appeals for the Federal Circuit·Decided November 21, 2006·No. 2005-1313·Published

Opinion

United States Court of Appeals for the Federal Circuit

ERRATA

November 21, 2006

Appeal No. 05-1313

Judge Rader’s Precedential Concurring in part opinion, Impax Laboratories v Aventis Pharm., No. 05-1313

Decided November 20, 2006

Page 1 of concurring in part opinion, lines 26 and 27:

Delete: “766 F.2d 531, 533 (Fed. Cir. 1985)”; insert in its place: “413 F.3d 1318, 1325- 26 (Fed. Cir. 2005)”

Free access — add to your briefcase to read the full text and ask questions with AI

Impax Laboratories, Inc. v. Aventis Pharmaceuticals, Inc., 468 F.3d 1366 (Fed. Cir. 2006).

468 F.3d 1366 (Impax Laboratories, Inc. v. Aventis Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re John A. Donohue
766 F.2d 531 (Federal Circuit, 1985)